Seres Therapeutics (MCRB) Misses Q1 EPS by 8c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street mostly rises as Fed holds key rate steady, deferring next likely hike to December
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: MCRB) | Delayed: 1.78 -0.02 (1.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.80 | 52 Week High | $44.51 | |||
| Open | $1.77 | 52 Week Low | $8.05 | |||
| Day High | $1.93 | P/E | N/A | |||
| Day Low | $1.68 | EPS | $0.00 | |||
| Volume | 75,005 | |||||
